Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| ST Develops next-generation bispecific ADCs for cancer treatment | $137M | Series B | Biotech | United States | Investors | |
| RL Develops first-in-class peptides for inflammatory disorders | $40M | Undisclosed | Biotech | United States | Investors Undisclosed | |
| P PetwealthCompany profile Provides at-home PCR diagnostics and AI-powered health intelligence for dogs and cats Provides at-home PCR diagnostics and AI-powered health intelligence for dogs and cats | $1.7M | Pre-SeedPre-seed | Biotech, Healthtech | United States | Investors Undisclosed | |
| KC Kytopen CorpCompany profile Develops non-viral, continuous flow cellular engineering technologies for cell therapy manufacturing Develops non-viral, continuous flow cellular engineering technologies for cell therapy manufacturing | Undisclosed | Series B | Biotech | United States | Investors | |
| SB Develops intelligent platform-driven macrocyclic peptide drug discovery | $150M | Series B | Biotech | China | Investors | |
| A AcurionCompany profile AI analysis of routine pathology images to identify cancer biomarkers for precision oncology. AI analysis of routine pathology images to identify cancer biomarkers for precision oncology. | $4.3M | Seed | Biotech, Healthtech | United States | Investors | |
| G Generates molecular data for drug development | €20M | Series A | Biotech | France | Investors | |
| F Develops biotech-powered hair supplements using proprietary microencapsulation | Undisclosed | Follow-OnUndisclosed | Biotech | United Kingdom | Investors | |
| AB Ambrosia BiosciencesCompany profile Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders. Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders. | $100M | Series B | Biotech | United States | Investors | |
| SB Scala BiodesignCompany profile Develops computational protein design technologies for therapeutic and industrial applications Develops computational protein design technologies for therapeutic and industrial applications | $16M | Series A | Biotech | Israel | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →